Core Viewpoint - Yuanxu Technology (08637) has resumed trading and experienced a price increase of nearly 14%, with a current price of HKD 1.91 and a trading volume of HKD 2.0204 million [1][4] Group 1: Company Announcement - On January 14, Yuanxu Technology announced its consideration to apply for listing on the Singapore Exchange's Catalist board to enhance its corporate image and broaden its shareholder base [1][4] - The company aims for a dual primary listing on both the Hong Kong Stock Exchange and the Singapore Exchange, pending compliance with the relevant requirements and regulations [1][4] - As of the announcement date, the company has engaged professional advisors to provide recommendations regarding the listing but has not yet submitted a formal application [1][4]

Group 1 - Yuanxu Technology (08637.HK) resumed trading and saw a nearly 14% increase, reaching a price of 2.05 HKD per share [1] - As of the report, the stock was up 13.89%, with a trading volume of 1.7701 million HKD [1]

Core Viewpoint - Yuanxu Technology (08637) has resumed trading with a nearly 14% increase in stock price, currently at HKD 2.05, with a trading volume of HKD 1.77 million [1] Group 1: Company Announcement - On January 14, Yuanxu Technology announced its consideration to apply for a dual primary listing on the Singapore Exchange to enhance its corporate image and broaden its shareholder base [1] - The company has engaged professional advisors to provide recommendations regarding the potential listing but has not yet submitted a formal application [1] - The dual listing is contingent upon meeting the requirements and conditions set by the Singapore Exchange, as well as applicable laws, rules, and regulations [1]

Core Viewpoint - Yuanxu Technology (08637) resumed trading with a nearly 14% increase, currently at HKD 2.05, with a trading volume of HKD 1.7701 million [1] Group 1: Company Announcement - On January 14, Yuanxu Technology announced its consideration to apply for a listing on the Singapore Exchange's Catalist board to enhance its corporate image and broaden its shareholder base [1] - The company aims for a dual primary listing on both the Hong Kong Stock Exchange and the Singapore Exchange, pending compliance with the requirements and regulations of the Singapore Exchange [1] - As of the announcement date, the company has engaged professional advisors to provide recommendations for the proposed listing but has not yet submitted a formal application [1]

Group 1 - The core announcement is that Yuanxu Technology (08637) will resume trading of its shares on January 15, 2026, at 9:00 AM [1]

Group 1 - The company Yuanxu Technology (08637) announced that its shares will resume trading on January 15, 2026, at 9:00 AM [1]

Group 1 - The core point of the article is that two companies, Dongyao Pharmaceutical-B and Yuanxu Technology, resumed trading on the Hong Kong stock market on January 15 [1] Group 2 - Dongyao Pharmaceutical-B and Yuanxu Technology are the specific companies mentioned that have resumed trading [1] - The news indicates a potential shift in market activity for these companies following their trading resumption [1]

Company News - CITIC Securities (06030.HK) reported a revenue of RMB 74.83 billion for the fiscal year 2025, representing a year-on-year increase of 28.75%, and a net profit of RMB 30.05 billion, up 38.46% year-on-year [2] - CITIC Bank (00998.HK) announced a total revenue of RMB 212.48 billion for 2025, a slight decrease of 0.55% year-on-year, while net profit increased by 2.98% to RMB 70.62 billion [2] - Beijing North Star Industrial (00588.HK) expects to continue reporting losses for the fiscal year ending December 31, 2025 [3] - Yuexiu Property (00123.HK) reported a cumulative contract sales amount of approximately RMB 106.21 billion for 2025, a decline of about 7.3% year-on-year, achieving 88.1% of its sales target [3] - Jiao Ge Peng You Holdings (01450.HK) achieved a total GMV of approximately RMB 6.49 billion in Q4 2025, a year-on-year increase of about 4.34%, with a cumulative GMV of RMB 16.02 billion for the year, up 6.23% [3] - Sai Jing Technology (00580.HK) anticipates a revenue of approximately RMB 2.25 billion for 2025, reflecting a year-on-year increase of about 40% due to increased revenue from flexible transmission business [3] - China General Nuclear Power New Energy (01811.HK) reported a cumulative power generation of 19,000 GWh for 2025, a decrease of 0.8% year-on-year, with variations in different energy sources [3] - Morning News Technology (02000.HK) reported an unaudited revenue of HKD 397 million for 2025, a decrease of 7.4% year-on-year [3] Financing and Buyback Activities - Chow Tai Fook Enterprises (00659.HK) applied for the registration of debt financing instruments totaling no more than RMB 5 billion [7] - Tencent Holdings (00700.HK) repurchased 1.006 million shares at a cost of approximately HKD 636 million, with repurchase prices ranging from HKD 626 to HKD 638 [7] - Xiaomi Group-W (01810.HK) repurchased 4 million shares for approximately HKD 151 million, with repurchase prices between HKD 37.61 and HKD 42.50 [7] Research and Development - Hutchison China MediTech (00013.HK) announced the publication of SACHI III study results in The Lancet [4] - Laka Pharmaceuticals-B (02105.HK) had its clinical trial application for the new drug LAE118 accepted by the U.S. FDA [5] Other News - Yuanxu Technology (08637.HK) announced a short suspension of trading starting January 14, pending the release of insider information [6] - Haidilao (06862.HK) redeemed USD 600 million of its 2.150% notes due in 2026 [2]

Group 1 - The company, Yuanxu Technology (08637.HK), is considering applying for a dual primary listing on the Singapore Exchange (SGX) to enhance its corporate image and broaden its shareholder base [1] - The company has submitted an application to the Hong Kong Stock Exchange (HKEX) for its shares to resume trading on January 15, 2026, at 9:00 AM [1] - The dual listing is contingent upon meeting the requirements and conditions set by the SGX, as well as applicable laws, rules, and regulations [1]

Core Viewpoint - Yuanxu Technology (08637) is considering applying for a dual primary listing on the Singapore Exchange to enhance its corporate image and broaden its shareholder base, pending compliance with relevant requirements and regulations [1] Group 1: Listing Strategy - The company is exploring the possibility of a dual primary listing on the Singapore Exchange, alongside its existing listing on the Hong Kong Stock Exchange [1] - Professional advisors have been appointed to provide guidance on the proposed listing, although a formal application has not yet been submitted [1] Group 2: Trading Resumption - The company has applied to the Hong Kong Stock Exchange for its shares to resume trading starting from January 15, 2026, at 9:00 AM [1]